Scarica l'app Stockscreener
15.75
4.43%
-0.73
Dopo l'orario di chiusura:
15.49
-0.26
-1.65%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$16.48
Aprire:
$16.23
Volume 24 ore:
139.83K
Relative Volume:
0.63
Capitalizzazione di mercato:
$434.46M
Reddito:
$30.43M
Utile/perdita netta:
$-18.15M
Rapporto P/E:
-18.53
EPS:
-0.85
Flusso di cassa netto:
$-9.08M
1 W Prestazione:
+1.32%
1M Prestazione:
+30.06%
6M Prestazione:
+177.29%
1 anno Prestazione:
+126.95%
Intervallo 1D:
$15.66
$16.43
Intervallo di 1 settimana:
$14.40
$16.59
Portata 52W:
$5.105
$17.47
Clearpoint Neuro Inc Stock (CLPT) Company Profile
Nome
Clearpoint Neuro Inc
Settore
Industria
Telefono
(949) 900-6833
Indirizzo
120 S. SIERRA AVENUE, SOLANA BEACH, CA
Confronta CLPT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CLPT
Clearpoint Neuro Inc
|
15.75 | 434.46M | 30.43M | -18.15M | -9.08M | -0.69 |
|
ABT
Abbott Laboratories
|
114.99 | 199.45B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
367.11 | 139.95B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
90.66 | 133.62B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
80.74 | 103.53B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
75.65 | 44.62B | 6.60B | 4.16B | 490.10M | 6.93 |
Clearpoint Neuro Inc Stock (CLPT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-07-25 | Ripresa | B. Riley Securities | Buy |
| 2023-10-24 | Iniziato | Stifel | Buy |
| 2023-02-16 | Ripresa | B. Riley Securities | Buy |
| 2022-04-05 | Ripresa | B. Riley Securities | Buy |
| 2021-03-18 | Iniziato | Lake Street | Buy |
| 2020-07-17 | Iniziato | B. Riley FBR | Buy |
Mostra tutto
Clearpoint Neuro Inc Borsa (CLPT) Ultime notizie
Long Term Trading Analysis for (CLPT) - Stock Traders Daily
Conway Capital Management Inc. Takes Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - MarketBeat
After Leaping 26% ClearPoint Neuro, Inc. (NASDAQ:CLPT) Shares Are Not Flying Under The Radar - Simply Wall St
ClearPoint: Fundamentals Continue To Improve (NASDAQ:CLPT) - Seeking Alpha
(CLPT) Proactive Strategies - Stock Traders Daily
(CLPT) Technical Pivots with Risk Controls - Stock Traders Daily
ClearPoint Neuro Inc (CLPT) Trading 3.92% Higher on Oct 9 - GuruFocus.com
Pekin Hardy Strauss Inc. Invests $541,000 in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - MarketBeat
Oppenheimer & Co. Inc. Takes Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
West Pharmaceutical Services (NYSE:WST) & ClearPoint Neuro (NASDAQ:CLPT) Critical Comparison - Defense World
Global MRI Guided Neurosurgical Ablation Market Poised for Steady Growth, Projected to Reach USD 227.56 Million by 2034 Driven by Growing Adoption and Advancements in Non-Cooled Laser Systems: FMI - GlobeNewswire Inc.
(CLPT) Investment Analysis - Stock Traders Daily
ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain - AccessWire
ClearPoint Neuro Inc (CLPT) Trading 6.12% Higher on Nov 14 - GuruFocus.com
ClearPoint (CLPT) Gains An FDA Approval, Driving Market Interest - Stocks Telegraph
ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Deliv - PharmiWeb.com
ClearPoint Neuro Makes History with First FDA-Approved Brain Gene Therapy Device | CLPT Stock News - StockTitan
ClearPoint Neuro fully repays $10M converted note - MSN
Q1 Earnings Estimate for CLPT Issued By B. Riley - MarketBeat
ClearPoint Neuro: Near-Term Volatility Is No Concern - Seeking Alpha
The ClearPoint Neuro, Inc. (NASDAQ:CLPT) Third-Quarter Results Are Out And Analysts Have Published New Forecasts - Yahoo Finance
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Q3 2024 Earnings Call Transcript - Insider Monkey
Earnings call: ClearPoint Neuro reports robust Q3 growth, eyes FDA approvals - Investing.com
ClearPoint Neuro Inc (CLPT) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ... By GuruFocus - Investing.com Canada
ClearPoint Neuro, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
ClearPoint Neuro, Inc. (CLPT) Reports Q3 Loss, Tops Revenue Estimates - MSN
ClearPoint Neuro Achieves Record Q3 Revenue Growth - TipRanks
Clearpoint Neuro earnings missed, revenue topped estimates By Investing.com - Investing.com UK
ClearPoint Neuro Reports Third Quarter 2024 Results - AccessWire
ClearPoint Neuro Inc (CLPT) Q3 2024 Earnings Report Preview: Wha - GuruFocus.com
ClearPoint Neuro Inc (CLPT) Q3 2024 Earnings Report Preview: What To Expect - Yahoo Finance
Those who invested in ClearPoint Neuro (NASDAQ:CLPT) five years ago are up 213% - Yahoo Finance
(CLPT) Trading Report - Stock Traders Daily
Vanguard Group Inc's Strategic Acquisition in ClearPoint Neuro I - GuruFocus.com
ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2024 - AccessWire
ClearPoint Neuro: Investors Enamored With Its Growth Prospects (NASDAQ:CLPT) - Seeking Alpha
ClearPoint Neuro (CLPT) Set to Announce Quarterly Earnings on Thursday - MarketBeat
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Sees Significant Increase in Short Interest - MarketBeat
Taylor Frigon Capital Management LLC Has $4.20 Million Stock Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - MarketBeat
CLPTClearPoint Neuro, Inc. Latest Stock News & Market Updates - StockTitan
ClearPoint Neuro (CLPT) Soars 6.9%: Is Further Upside Left in the Stock? - MSN
Investors bid ClearPoint Neuro (NASDAQ:CLPT) up US$51m despite increasing losses YoY, taking five-year CAGR to 27% - Simply Wall St
CLPT Stock Touches 52-Week High at $13.5 Amidst Strong Yearly Growth - Investing.com
ClearPoint Neuro to Announce Third Quarter 2024 Results November 7, 2024 - ForexTV.com
ClearPoint Neuro, Inc. (CLPT): A Bear Case Theory - Insider Monkey
Cubist Systematic Strategies LLC Takes $419,000 Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
Cubist Systematic Strategies LLC Acquires Shares of 77,750 ClearPoint Neuro, Inc. (NASDAQ:CLPT) - MarketBeat
Marshall Wace LLP Buys 38,984 Shares of ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
Clearpoint Neuro Inc Azioni (CLPT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.35%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):